In-vitro fertilization (IVF) Services Market is Expected to Reach $6.2 Billion by 2025, Growing with a CAGR of 16.9%, During the Forecast Period of 2018 to 2025, says Esticast Research and Consulting
ABOUT THIS REPORT
new report guarantee
The market report will provide latest insights, estimates, and market development. Moreover, we guarantee a latest report refreshed with latest progresses. The report will an all-inclusive evaluation of the market across all segments, regions, and counties.
As per the report “In Vitro Fertilization (IVF) Market By Product (Reagents, Equipment), By Type of Cycles (Fresh non-donor, Frozen non-donor, Fresh donor, Frozen donor), By End User (Fertility clinics and surgical centers, Hospital and research laboratories, Cryobanks), Industry Trends, Estimation & Forecast, 2018 – 2025″. IVF Market is Expected to Reach $6.2 Billion by 2025, Growing with a CAGR of 16.9%, During the Forecast Period of 2018 to 2025.
In 2017, the fertility clinics & surgical centers segment generated the highest revenue share. Among major regions, Asia Pacific market is expected to grow with the fastest growth rate in the near future.
“Rapidly changing lifestyle, increasing marital age of people, rising alcohol consumption and hiking obesity among females are the major factors which are stimulating the infertility rate among the individuals, eventually assisting the in-vitro fertilization market growth. However, high chances of failure in conceiving through donor embryo and high cost of IVF procedures can considerably hinder the market growth”
Files are delivered directly into your account within a few minutes of purchase.
Fresh Donor IVF technology has emerged out as the major revenue contributor for the global market
On the basis of technology, the fresh non- donor IVF segment accounted for nearly 40% share of the overall market revenue. In a fresh non donor IVF cycle, eggs are retrieved from the patient itself and immediately fertilized with the male partner’s sperm, with the resulting fresh embryos transferred back to the recipient. This procedure is comparatively cheaper and safer to other ART methodologies. Moreover, higher success rates witnessed while conducting fresh IVF cycle have resulted into the higher adoption of this very technology. Apart from that, most women prefer to try fertility treatment using their own eggs first, because they want their child to be a product of their own body. However, this procedure is not suitable for the women who are above the age of 37 years.
On the other hand, a sudden increase in the number of middle aged women (37-45 years), seeking for conceiving a child, is creating a positive influence over the demand of fresh donor IVF treatment. As per the statistics revealed by American Society of Reproductive medicine, while conducting a research on IVF results, live birth rates from fresh transfer of embryos from donor eggs were 15-20% higher than those from frozen embryo transfer of embryos from donor eggs over the same duration. More than 47000 live births in the U.S. have taken place through fresh donor IVF till yet.
why buy this report?
The report will provide deep analysis of historic data, qualitative insights, product benchmarking, and premium market forecast.
Asia Pacific IVF market to grow with the fastest CAGR during the forecast period of 2018-2025
Owing to increasing awareness regarding ART and rising number of infertile population among developing countries such as India and China, the IVF market is expected to witness various lucrative opportunities in the Asia Pacific. Apart from that, persistently rising disposable income of people has generated a considerable hike in health expenditure. In addition to this, Asia-pacific is one of the most preferred destination for medical tourism. A number of Southeast Asian countries like Thailand, Singapore, Malaysia and India in South Asia, have become important destinations for infertility patients from both developed and developing countries.
To know more about the report, visit at – https://www.esticastresearch.com/report/ivf-in-vitro-fertilization-market
Fallopian tube blockages and increasing prevalence of endometriosis among Chinese and Indian women can be inferred as an influential cause for proliferating the IVF market in the very region. As per a research report displayed by NCBI, Asians compared to non-Asians have a higher prevalence of endometriosis. In India, approximately 10-15% of married couples are infertile and 27.5 million people in the country are seeking treatment for infertility in the country. Also, there are various government programs which are being launched by the governments in order to promote the usage of IVF in the Asia-Pacific region. For example, Indian government recently launched a scheme named “Jiyo Parsi” for arresting the declining population of Parsi Zoroastrian Community in the country, by providing subsidized IVF treatment to the Parsi couples.
Some key players of the IVF market are Cook Medical, Inc. (U.S.), CooperSurgical, Inc. (U.S.), Irvine Scientific (U.S.), Thermo Fisher Scientific, Inc., ESCO Micro Pte. Limited (Singapore), IVFtech ApS (Denmark), The Baker Company, Inc. (U.S.), EMD Serono, Inc. (U.S.), Amedes MVZ Cologne GmbH, Bloom Fertility and Healthcare, Fertility Center Berlin, Fertility Center of San Antoni, AMP Center St Roch, AVA Clinic Scanfert and Bangkok IVF center.